UnknownNot Applicable

Spot tm Tattooing of Biopsied Axillary Lymph Nodes With Ultrasound Guided in Breast Cancer Patients Prior to Surgery

Israel50 participantsStarted 2016-01

Plain-language summary

To assess feasibility and clinical utility of marking biopsied axillary lymph nodes with Spot at time of biopsy.

Who can participate

Age range18 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women with findings suspicious of breast cancer (or known breast cancer) who undergo axillary lymph node biopsy Exclusion Criteria: * Inability to sign Informed Consent

What they're measuring

Intra operative identification the Spot TM marked node at the time of surgery

Timeframe: Within 1 year of enrollment

Trial details

NCT IDNCT02617264

SponsorKaplan Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-10

Contact for this trial

Tanir Allweis, MD

taniral@clalit.org.il

View on ClinicalTrials.gov More Breast Cancer trials